Join the IAJ (the Institute of Actuaries of Japan) as they deep dive the Japan mortality and morbidity trend impacted by COVID-19. During COVID-19, Japan experienced increasing COVID-19 patients and deteriorated morbidity trend mainly due to deemed hospitalization. This was introduced to regard the treatment under the doctors' supervision outside of the hospital as hospitalization, given shortage of hospital beds, and add accident death benefit payment triggered by COVID-19. Expect coverage on the mortality/morbidity analysis comparison in Japan, US and globally, as well as comprehensively discuss how Japanese insurers identified solutions to respond to the changing market. Also, you'll discuss consumers' needs and how more uncertainty drives them to prepare individual lifetime retirement income.
Key learning outcomes include:
- Learn the analysis of mortality / morbidity trend comparison Japan, US and global
- Understand the financial impact by COVID-19 and morbidity risk management
- Learn how Japanese insurers respond to the evolving needs from customers as a result of pandemic
- Assess a strategy for individuals to generate lifetime retirement income
TRACK: Assumptions and Experience Studies (Mortality, Longevity Improvements, Interest Rates, NGE, Etc.);ERM/ Capital Risk/ Climate Change